Burkhardt Laufer

Title: Burkhardt Laufer: Innovator in Hydrogel Prodrug Compositions

Introduction

Burkhardt Laufer is a notable inventor based in Dossenheim, Germany. He has made significant contributions to the field of hydrogel prodrug compositions, particularly focusing on applications in ocular treatments. With a total of 5 patents to his name, Laufer's work exemplifies innovation in drug delivery systems.

Latest Patents

One of Laufer's latest patents is centered around hydrogel cross-linked hyaluronic acid prodrug compositions and methods. This invention involves hydrogel prodrug compositions that include cross-linked hyaluronic acid (HA) or its derivatives. The cross-linker system in these compositions features a biodegradable spacer, allowing for the conjugation of a drug-linker that can release the drug under physiological conditions. Additionally, the patent outlines methods for preparing these hydrogel prodrug compositions and their application in treating ocular conditions.

Career Highlights

Throughout his career, Burkhardt Laufer has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Ascendis Pharma and its Ophthalmology Division. His expertise in hydrogel technology has positioned him as a key player in the development of innovative drug delivery systems.

Collaborations

Laufer has collaborated with several professionals in his field, including Harald Rau and Thomas Knappe. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Burkhardt Laufer's contributions to hydrogel prodrug compositions highlight his innovative spirit and dedication to improving drug delivery methods. His work continues to influence the field of ophthalmology and beyond.